Original Source(s)
Related Content
CGM Shows Potential for Diagnosing Diabetes in Pregnancy
Early glucose patterns may help identify risk, but evidence doesn't support replacing standard testing.
May 5, 2026
-
3 min
Retatrutide Shows 28% Weight Loss in Phase 3 Trial
Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.
May 21, 2026
-
2 min
Prepregnancy Lipids Predict HDP Risk
A large Swedish cohort found cardiometabolic biomarkers measured up to decades before pregnancy were associated with hypertensive disorders — with risk apparent even below standard diagnostic thresholds.
May 5, 2026
-
4 min
